Literature DB >> 8535614

Diminished expression of the extracellular domain of bullous pemphigoid antigen 2 (BPAG2) in the epidermal basement membrane of patients with generalized atrophic benign epidermolysis bullosa.

G Pohla-Gubo1, Z Lazarova, G J Giudice, M Liebert, A Grassegger, H Hintner, K B Yancey.   

Abstract

Generalized atrophic benign epidermolysis bullosa (GABEB) is a nonlethal form of junctional epidermolysis bullosa characterized by generalized skin and mucosal blisters that heal with atrophy; other features include alopecia, nail dystrophy, large melanocytic nevi, and autosomal recessive inheritance. The specific aim of this study was to identify an abnormality in epidermal basement membrane adhesion molecules in well characterized GABEB patients that would explain why these subjects' epidermis separates from their epidermal basement membrane. Cryostat sections of nonlesional skin from 8 GABEB patients in 5 different families as well as skin from normal volunteers (controls) were studied by indirect immunofluorescence microscopy using rabbit antiserum directed against a BPAG1 fusion protein or monoclonal antibodies directed against the extracellular domain of BPAG2 (HD18 and 233), epiligrin (P1E1), laminin 5 (GB3), types IV and VII collagen, or integrin subunits alpha 2, alpha 3, beta 1, alpha 6, or beta 4. In these studies, monoclonal antibodies HD18 and 233 showed no reactivity and diminished reactivity, respectively, to the epidermal BM of all GABEB patients. Interestingly, in one patient, the absent or diminished reactivities of monoclonal anti-BPAG2 antibodies were limited to well demarcated portions of an otherwise intact epidermal basement membrane. Moreover, BPAG1, epiligrin, laminin 5, types IV and VII collagen, and all integrin subunits under study were expressed in the same manner in both GABEB and normal human skin. These findings identify an abnormality in the extracellular domain of BPAG2 in the skin of GABEB patients. BPAG2 (type XVII collagen) is a transmembrane, hemidesmosome-associated molecule whose extracellular domain resides at the exact level where blisters develop in the skin of patients with GABEB.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535614     DOI: 10.1111/j.1600-0625.1995.tb00245.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

1.  Pregnant women have increased incidence of IgE autoantibodies reactive with the skin and placental antigen BP180 (type XVII collagen).

Authors:  Megan H Noe; Kelly A N Messingham; Debra S Brandt; Janet I Andrews; Janet A Fairley
Journal:  J Reprod Immunol       Date:  2010-05-14       Impact factor: 4.054

2.  Epidermolysis bullosa with pyloric atresia: novel mutations in the beta4 integrin gene (ITGB4).

Authors:  L Pulkkinen; D U Kim; J Uitto
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

3.  Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180.

Authors:  Kelly A N Messingham; Amber Onoh; Elizabeth M Vanderah; George J Giudice; Janet A Fairley
Journal:  Hybridoma (Larchmt)       Date:  2012-04

4.  Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation.

Authors:  T N Darling; C Yee; J W Bauer; H Hintner; K B Yancey
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

5.  Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice.

Authors:  Edit B Olasz; Jooyoung Roh; Carole L Yee; Ken Arita; Masashi Akiyama; Hiroshi Shimizu; Jonathan C Vogel; Kim B Yancey
Journal:  J Invest Dermatol       Date:  2007-07-26       Impact factor: 8.551

6.  Severe mucous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel plectin gene mutation.

Authors:  Ulrike Schara; Jens Tücke; Wilhelm Mortier; Thomas Nüsslein; Fatima Rouan; Ellen Pfendner; Detlef Zillikens; Leena Bruckner-Tuderman; Jouni Uitto; Gerhard Wiche; Rolf Schröder
Journal:  Eur J Pediatr       Date:  2004-02-13       Impact factor: 3.183

7.  ADAM17 Inhibitors Attenuate Corneal Epithelial Detachment Induced by Mustard Exposure.

Authors:  Andrea DeSantis-Rodrigues; Yoke-Chen Chang; Rita A Hahn; Iris P Po; Peihong Zhou; C Jeffrey Lacey; Abhilash Pillai; Sherri C Young; Robert A Flowers; Michael A Gallo; Jeffrey D Laskin; Donald R Gerecke; Kathy K H Svoboda; Ned D Heindel; Marion K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-04       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.